Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese.
- 1 February 1991
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 22 (2) , 203-208
- https://doi.org/10.1161/01.str.22.2.203
Abstract
We analyzed the serum concentrations of lipids and lipoproteins and the prevalence of other risk factors in a case-control study of 304 consecutive Chinese patients with acute stroke (classified as cerebral infarction, lacunar infarction, or intracerebral hemorrhage) and 304 age- and sex-matched controls. For all strokes we identified the following risk factors: a history of ischemic heart disease, diabetes mellitus, or hypertension; the presence of atrial fibrillation or left ventricular hypertrophy; a glycosylated hemoglobin A1 concentration of greater than 9.1%; a fasting plasma glucose concentration 3 months after stroke of greater than 6.0 mmol/l; a serum triglyceride concentration 3 months after stroke of greater than 2.1 mmol/l; and a serum lipoprotein(a) concentration of greater than 29.2 mg/dl. We found the following protective factors: a serum high density lipoprotein-cholesterol concentration of greater than 1.59 mmol/l and a serum apolipoprotein A-I concentration of greater than or equal to 106 mg/dl. The patterns of risk factors differed among the three stroke subtypes. When significant risk factors were entered into a multiple logistic regression model, we found a history of hypertension, a high serum lipoprotein(a) concentration, and a low apolipoprotein A-I concentration to be independent risk factors for all strokes. The attributable risk for hypertension was estimated to be 24% in patients aged greater than or equal to 60 years. In this population, in which cerebrovascular diseases are the third commonest cause of mortality, identification of risk factors will allow further studies in risk factor modification for the prevention of stroke.Keywords
This publication has 18 references indexed in Scilit:
- Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention TrialNew England Journal of Medicine, 1989
- Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.Journal of Clinical Investigation, 1988
- Measurement of total HDL, HDL2 and HDL3 by dextran sulfate—MgCl2 precipitation technique in human serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarctionAtherosclerosis, 1986
- Serum lipids in the People's Republic of China. Comparison of Western and Eastern populations.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohortJournal of Chronic Diseases, 1984
- Serum triglyceride and risk of coronary heart disease, stroke, and total mortality in Japanese-American men.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?The Lancet, 1979
- Calculation of Attributable Risks from Epidemiological DataInternational Journal of Epidemiology, 1978
- Serum lipid changes following the completed stroke syndromePostgraduate Medical Journal, 1975